The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study

A significant knowledge gap exists concerning the geographical distribution of nontuberculous mycobacteria (NTM) isolation worldwide. To provide a snapshot of NTM species distribution, global partners in the NTM-Network European Trials Group (NET) framework (www.ntm-net.org), a branch of the Tuberculosis Network European Trials Group (TB-NET), provided identification results of the total number of patients in 2008 in whom NTM were isolated from pulmonary samples. From these data, we visualised the relative distribution of the different NTM found per continent and per country. We received species identification data for 20 182 patients, from 62 laboratories in 30 countries across six continents. 91 different NTM species were isolated. Mycobacterium avium complex (MAC) bacteria predominated in most countries, followed by M. gordonae and M. xenopi. Important differences in geographical distribution of MAC species as well as M. xenopi, M. kansasii and rapid-growing mycobacteria were observed. This snapshot demonstrates that the species distribution among NTM isolates from pulmonary specimens in the year 2008 differed by continent and differed by country within these continents. These differences in species distribution may partly determine the frequency and manifestations of pulmonary NTM disease in each geographical location. Species distribution among nontuberculous mycobacteria isolates from pulmonary specimens is geographically diverse http://ow.ly/npu6r

[1]  L. Larsson,et al.  Isolation of Mycobacterium malmoense from the environment in Zaire. , 1995, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[2]  Robert Horsburgh,et al.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. , 2007, American journal of respiratory and critical care medicine.

[3]  R. Thomson.  Changing Epidemiology of Pulmonary Nontuberculous Mycobacteria Infections , 2010, Emerging infectious diseases.

[4]  Rapid increase of the incidence of lung disease due to Mycobacterium kansasii in Japan. , 1983, Chest.

[5]  E. Palenque,et al.  Mycobacterium colombiense sp. nov., a novel member of the Mycobacterium avium complex and description of MAC-X as a new ITS genetic variant. , 2006, International journal of systematic and evolutionary microbiology.

[6]  Nalin Rastogi,et al.  Burden of Unidentifiable Mycobacteria in a Reference Laboratory , 2001, Journal of Clinical Microbiology.

[7]  D. van Soolingen,et al.  Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands , 2009, Thorax.

[8]  Re-analysis of 178 previously unidentifiable Mycobacterium isolates in the Netherlands in 1999-2007. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[9]  Chun-Ta Huang,et al.  Pulmonary infection caused by nontuberculous mycobacteria in a medical center in Taiwan, 2005-2008. , 2012, Diagnostic microbiology and infectious disease.

[10]  Young Kil Park,et al.  Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. , 2006, Chest.

[11]  R. Chaisson,et al.  Nontuberculous mycobacteria: defining disease in a prospective cohort of South African miners. , 1999, American journal of respiratory and critical care medicine.

[12]  D. Wagner,et al.  Epidemiologie der nichttuberkulösen mykobakteriellen Erkrankungen in Deutschland und weltweit , 2011, Der Pneumologe.

[13]  R. Kroppenstedt,et al.  Proposal to elevate the genetic variant MAC-A, included in the Mycobacterium avium complex, to species rank as Mycobacterium chimaera sp. nov. , 2004, International journal of systematic and evolutionary microbiology.

[14]  T. Marras,et al.  Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997–2003 , 2007, Thorax.

[15]  D. van Soolingen,et al.  Nontuberculous Mycobacteria in Respiratory Tract Infections, Eastern Asia , 2011, Emerging infectious diseases.

[16]  C. Daley,et al.  Epidemiology of human pulmonary infection with nontuberculous mycobacteria. , 2002, Clinics in chest medicine.

[17]  J. Bennedsen,et al.  Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[18]  L. Lebrun,et al.  Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients , 2006, European Respiratory Journal.

[19]  D. van Soolingen,et al.  The rising incidence and clinical relevance of Mycobacterium malmoense: a review of the literature. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[20]  R. Hayes,et al.  Mycobacterium kansasii and M. scrofulaceum isolates from HIV-negative South African gold miners: incidence, clinical significance and radiology. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[21]  J. Gerberding,et al.  Incidence and Clinical Implications of Isolation of Mycobacterium kansasii: Results of a 5-Year, Population-Based Study , 1998, Annals of Internal Medicine.

[22]  Endemic incidence of infections caused by Mycobacterium kansasii in the Karviná district in 1968-1995 (analysis of epidemiological data--review). , 1997, Central European journal of public health.

[23]  A. Crampin,et al.  Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi. , 2001, The Journal of infectious diseases.